Alyeska Investment Group’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.98M | Sell |
258,678
-150,000
| -37% | -$3.47M | 0.02% | 399 |
|
|
2025
Q1 | $11M | Buy |
408,678
+63,762
| +18% | +$1.72M | 0.04% | 299 |
|
|
2024
Q4 | $18.5M | Buy |
344,916
+141,732
| +70% | +$7.59M | 0.07% | 267 |
|
|
2024
Q3 | $9.23M | Buy |
203,184
+3,800
| +2% | +$173K | 0.05% | 302 |
|
|
2024
Q2 | $8.35M | Buy |
199,384
+6,338
| +3% | +$265K | 0.05% | 289 |
|
|
2024
Q1 | $7.27M | Sell |
193,046
-4,444
| -2% | -$167K | 0.04% | 297 |
|
|
2023
Q4 | $2.12M | Buy |
197,490
+22,490
| +13% | +$241K | 0.01% | 347 |
|
|
2023
Q3 | $1.76M | Buy |
+175,000
| New | +$1.76M | 0.01% | 381 |
|